Document Detail


Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice.
MedLine Citation:
PMID:  20844003     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mechanisms maintaining the growth of a "semi-foreign" fetus within the maternal uterus via immune tolerance remain unclear. CD4(+)CD25(+) regulatory T (Treg) cells have been implicated in the maintenance of maternal-fetal immune tolerance. Additionally, 17β-estradiol (E2) is able to initiate immune suppression through CD4(+)CD25(+) Treg cells during early pregnancy. Little is known, however, regarding the relationship between progesterone (P4) and immune tolerance during midterm pregnancy, an important period, characterized by higher levels of P4 but lower levels of E2 in the serum. Here, we examined the effects of P4 on the expansion and function of systemic and local uterine CD4(+)CD25(+) Treg cells during midterm pregnancy in mice. Using in vivo and in vitro models, we provide the first evidence that P4 not only increases the proportion of CD4(+)CD25(+) Treg cells and IL-10 expression but also enhances their suppressive function. Moreover, at physiological doses relevant to midterm pregnancy, P4, but not E2, converts CD4(+)CD25(-) T cells into CD4(+)CD25(+) Treg cells. This conversion was inhibited in vitro by the nuclear P4 receptors antagonist RU 486 and in vivo in P4-treated ovariectomized and pseudopregnant mice models, suggesting that P4 expands Treg populations via nuclear P4 receptors. Furthermore, RU 486 significantly reduced the quantity and function of Treg cells in the fetal-maternal interface before the onset of induced abortion. Interestingly, with decreasing Foxp3, proinflammatory factors increased. Together, the present results demonstrate that P4 is an important regulator of systemic and local CD4(+)CD25(+) Treg cells, which are involved in maintaining maternal-fetal immune tolerance during midterm pregnancy.
Authors:
Guanping Mao; Junpeng Wang; Youmin Kang; Ping Tai; Jing Wen; Qiang Zou; Ge Li; Hong Ouyang; Guoliang Xia; Bin Wang
Related Documents :
8345473 - Cellular dynamics of growth in sheep and goat synepitheliochorial placentomes: an autor...
8540323 - Glycoproteins of the aspartyl proteinase gene family secreted by the developing placenta.
19856263 - Perinatal outcomes in isolated single umbilical artery.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-15
Journal Detail:
Title:  Endocrinology     Volume:  151     ISSN:  1945-7170     ISO Abbreviation:  Endocrinology     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-21     Completed Date:  2010-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5477-88     Citation Subset:  AIM; IM    
Affiliation:
State Key Laboratory for Agro-Biotechnology, College of Biological Science, China Agricultural University, Beijing 100193, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Western
Cells, Cultured
Estradiol / analogs & derivatives,  blood,  pharmacology
Female
Lymphocyte Count
Mice
Mifepristone / pharmacology
Pregnancy
Progesterone / blood,  pharmacology*
Radioimmunoassay
T-Lymphocytes, Regulatory / cytology*,  drug effects,  immunology
Uterus / cytology*,  drug effects,  immunology
Chemical
Reg. No./Substance:
129453-61-8/fulvestrant; 50-28-2/Estradiol; 57-83-0/Progesterone; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cyclin G2 regulates adipogenesis through PPAR gamma coactivation.
Next Document:  Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signali...